wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36876315-01618C88-EB02-48A6-91C1-3CE8EFEC99D1
Q36876315-01618C88-EB02-48A6-91C1-3CE8EFEC99D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36876315-01618C88-EB02-48A6-91C1-3CE8EFEC99D1
Angiosarcoma outcomes and prognostic factors: a 25-year single institution experience.
P2860
Q36876315-01618C88-EB02-48A6-91C1-3CE8EFEC99D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36876315-01618C88-EB02-48A6-91C1-3CE8EFEC99D1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
34104c4f204ac518001ebf248dfb97aadbfc8395
P2860
Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO).